@article{10661,
  keywords = {All-cause mortality, Cardiovascular outcomes, Effect modifier, Hospitalization for heart failure, Major adverse cardiovascular events, obesity, Sodium-glucose cotransporter-2 inhibitors},
  author = {K. Suissa and S. Schneeweiss and A. Douros and H. Yin and E. Patorno and L. Azoulay},
  title = {Obesity as a modifier of the cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes},
  year = {2022},
  journal = {Diabetes Res Clin Pract},
  volume = {192},
  edition = {2022/09/28},
  pages = {110094},
  isbn = {0168-8227},
  doi = {10.1016/j.diabres.2022.110094},
  note = {1872-8227
Suissa, Karine
Schneeweiss, Sebastian
Douros, Antonios
Yin, Hui
Patorno, Elisabetta
Azoulay, Laurent
Journal Article
Ireland
Diabetes Res Clin Pract. 2022 Sep 24;192:110094. doi: 10.1016/j.diabres.2022.110094.},
  language = {eng},
}